FDMT Income Tax Expense from 2010 to 2024

FDMT Stock  USD 7.50  0.12  1.57%   
4D Molecular Income Tax Expense yearly trend continues to be comparatively stable with very little volatility. Income Tax Expense is likely to outpace its year average in 2024. From the period from 2010 to 2024, 4D Molecular Income Tax Expense quarterly data regression had mean square error of 9.4 T and mean deviation of  1,923,137. View All Fundamentals
 
Income Tax Expense  
First Reported
2010-12-31
Previous Quarter
5.6 M
Current Value
5.9 M
Quarterly Volatility
M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check 4D Molecular financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among 4D Molecular's main balance sheet or income statement drivers, such as Net Interest Income of 9.6 M, Interest Income of 9.6 M or Depreciation And Amortization of 4.2 M, as well as many indicators such as Price To Sales Ratio of 36.34, Dividend Yield of 0.0 or PTB Ratio of 2.7. FDMT financial statements analysis is a perfect complement when working with 4D Molecular Valuation or Volatility modules.
  
Check out the analysis of 4D Molecular Correlation against competitors.

Latest 4D Molecular's Income Tax Expense Growth Pattern

Below is the plot of the Income Tax Expense of 4D Molecular Therapeutics over the last few years. It is 4D Molecular's Income Tax Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in 4D Molecular's overall financial position and show how it may be relating to other accounts over time.
Income Tax Expense10 Years Trend
Pretty Stable
   Income Tax Expense   
       Timeline  

FDMT Income Tax Expense Regression Statistics

Arithmetic Mean374,684
Coefficient Of Variation806.06
Mean Deviation1,923,137
Median(89,000)
Standard Deviation3,020,168
Sample Variance9.1T
Range12.3M
R-Value0.21
Mean Square Error9.4T
R-Squared0.05
Significance0.44
Slope144,599
Total Sum of Squares127.7T

FDMT Income Tax Expense History

20245.9 M
20235.6 M
2022-6.4 M
2021-3 M
2020-152 K
20193.6 M
2018848 K

About 4D Molecular Financial Statements

4D Molecular shareholders use historical fundamental indicators, such as Income Tax Expense, to determine how well the company is positioned to perform in the future. Although 4D Molecular investors may analyze each financial statement separately, they are all interrelated. The changes in 4D Molecular's assets and liabilities, for example, are also reflected in the revenues and expenses on on 4D Molecular's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Income Tax Expense5.6 M5.9 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for FDMT Stock Analysis

When running 4D Molecular's price analysis, check to measure 4D Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4D Molecular is operating at the current time. Most of 4D Molecular's value examination focuses on studying past and present price action to predict the probability of 4D Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4D Molecular's price. Additionally, you may evaluate how the addition of 4D Molecular to your portfolios can decrease your overall portfolio volatility.